Viewing StudyNCT06435260



Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06435260
Status: RECRUITING
Last Update Posted: 2024-06-25
First Post: 2024-05-24

Brief Title: To Explore the Efficacy of Hypofractionated Radiotherapy Followed by AG Regimen Chemotherapy Plus Camrelizumab Immunotherapy as Neoadjuvant Therapy for Locally Advanced Pancreatic Cancer
Sponsor: Hebei Medical University Fourth Hospital
Organization: Hebei Medical University Fourth Hospital

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-06-17
Start Date Type: ESTIMATED
Primary Completion Date: 2025-06-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-06-01
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-24
First Submit QC Date: May 29 2024
Study First Post Date: 2024-05-30
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-13
Last Update Post Date: 2024-06-25
Last Update Post Date Type: ACTUAL